During the past decade, Nottingham City Hospital; Oncology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nottingham City Hospital; Oncology" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Nottingham City Hospital; Oncology" are "Breast Cancer" (7 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Breast Neoplasms" (1 trials), "Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Nottingham City Hospital; Oncology" in a lesser frequency.

Most popular intervention types in "Nottingham City Hospital; Oncology" are "Drug" (13 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (5 trials), "Docetaxel" (4 trials), "Atezolizumab" (3 trials), "Pertuzumab" (3 trials) and "Trastuzumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Nottingham City Hospital; Oncology" are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Nottingham City Hospital; Oncology". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Nottingham City Hospital; Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nottingham City Hospital; Oncology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".